VP5-deficient mutant virus induced protection against challenge with very virulent infectious bursal disease virus of chickens

Vaccine

Volumn 28, Issue 21, 2010, Pages 3735-3740

  Qin, Liting ^a   Qi, Xiaole ^a   Gao, Yulong ^a   Gao, Honglei ^a   Lu, Xuehua ^a   Wang, Yongqiang ^a   Bu, Zhigao ^a   Wang, Xiaomei ^a  

^a Harbin Veterinary Research Institute   (China)

Author keywords

Candidate vaccine; Infectious bursal disease virus; Replication and pathogenicity; VP5

Indexed keywords

AVIAN INFLUENZA VACCINE; INACTIVATED VACCINE; NONSTRUCTURAL PROTEIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE TECHNOLOGY; HEMAGGLUTINATION INHIBITION TEST; IMMUNE DEFICIENCY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; INOCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; BIRNAVIRIDAE INFECTIONS; BURSA OF FABRICIUS; CELLS, CULTURED; CHICKENS; HEMAGGLUTINATION INHIBITION TESTS; INFECTIOUS BURSAL DISEASE VIRUS; MOLECULAR SEQUENCE DATA; POULTRY DISEASES; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 77953133201     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.102     Document Type: Article

References (28)

1. McFerran J.B., McNulty M.S., Killop E.R., Connor T.J., McCracken R.M., Collins P.S., et al. Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian Pathol 9 3 (1980) 395-404
2. Müller H., Islam M.R., and Raue R. Research on infectious bursal disease-the past, the present and the future. Vet Microbiol 97 (2003) 153-165
3. Nieper H., and Müller H. Susceptibility of chicken lymphoid cells to infectious burasl disease virus does not correlate with the presence of specific binding sites. J Gen Virol 77 (1996) 1129-1237
4. Dobos P., Hill B.J., Hallett R., Kells D.T., Becht H., and Teninges D. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32 (1979) 593-605
5. Mundt E., Beyer J., and Müller H. Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol 76 (1995) 437-443
6. Müller H., and Becht H. Biosynthesis of virus specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious and incomplete particles. J Virol 44 1 (1982) 384-392
7. Von Einem U.I., Gorbalenya A.E., Schirrmeier H., Behrens S.E., Letzel T., and Mundt E. VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase. J Gen Virol 85 (2004) 2221-2229
8. Lombardo E., Maraver A., Espinosa L., Fernández-Arias A., and Rodriguez J.F. VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 277 (2000) 345-357
9. Mundt E., Köllner B., and Kretzschmar D. VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol 71 7 (1997) 5647-5651
10. Yao K., Goodwin M.A., and Vakharia V.N. Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol 72 4 (1998) 2647-2654
11. Yao K., and Vakharia V.N. Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus possible role in viral pathogenesis. Virology 285 (2001) 50-58
12. Boot H.J., Dokic K., and Peeters B.P.H. Comparison of RNA and cDNA transfection methods for rescue of infectious bursal disease virus. J Virol Methods 97 1-2 (2001) 67-76
13. Qi X.L., Gao Y.L., Gao H.L., Deng X.Y., Bu Z.G., Wang X.Y., et al. An improved method for infectious bursal disease virus rescues using RNA polymerase II system. J Virol Methods 142 1-2 (2007) 81-88
14. Qi X.L., Gao H.L., Gao Y.L., Qin L.T., Wang Y.Q., Gao L., et al. Naturally occurring mutation at residues 253 and 284 in VP2 contribute to the cell tropism and virulence of very virulent infectious bursal disease virus. Antiviral Res 84 (2009) 225-233
15. Wang X.M., Zhang H.S., Gao H.L., Fu C.Y., Gao Y.L., and Ju Y.L. Changes in VP3 and VP5 genes during the attenuation of the very virulent infectious bursal disease virus strain Gx isolated in China. Virus Gene 34 (2007) 67-73
16. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 2 (1991) 193-199
17. Qin L.T., Qi X.L., Gao H.L., Gao Y.L., Bu Z.G., and Wang X.M. Exchange of the VP5 of Infectious Bursal Disease Virus in a serotype I strain with that of a serotype II strain reduced the viral replication and cytotoxicity. J Microbiol 47 3 (2009) 344-350
18. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 27 (1938) 493-497
19. SchrÖder A., van Loon A.A.W.M., Goovaerts D., and Mundt E. Chimeras in noncoding region between serotypes I and II of segment A of infectious bursal disease virus are viable and show pathogenic phenotype in chickens. J Gen Virol 81 (2000) 533-540
20. Lucio B., and Hitchner S.B. Immunosuppression and active response induced by infectious bursal disease virus in chickens with passive antibodies. Avian Dis 24 1 (1979) 189-196
21. Shaw I., and Davison T.F. Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titer of challenge virus and chicken genotype. Vaccine 18 (2000) 3230-3241
22. Boot H.J., terHuurne A.A., Hoekman A.J., Pol J.M., Gielkens A.L.J., and Peeters B.P.H. Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure. J Virol 76 20 (2002) 10346-10355
23. World Organisation for Animal Health (OIE). Manual of diagnostic tests and vaccines for terrestrial animals. Chapter 2.3.4. Avian influenza (2009), World Organisation for Animal Health, Paris, France
24. Bech H. Infectious bursal disease virus. Curr Top Microbiol Immunol 90 (1980) 107-121
25. Lasher H.N., and Shane S.M. Infectious bursal disease. Worlds Poult Sci J 50 (1994) 133-166
26. Faragher J.T., Allan W.H., and Wyeth P.J. Immunosuppressive effect of infectious bursal agent on vaccination against Newcastle disease. Vet Rec 95 (1974) 385-388
27. Sharma J.M., Dohms J.E., and Metz A.L. Comparative pathogenesis of serotype 1 and variant serotype 1 isolates of infectious bursal disease virus and their effect on humoral and cellular immune competence of specific-pathogen-free chickens. Avian Dis 33 (1989) 112-124
28. Van Oirschot J.T. Diva vaccines that reduce virus transmission. J Biotechnol 73 (1999) 195-205